Skip to main content
. 2022 Feb 16;9(3):339–350. doi: 10.1002/acn3.51519

Figure 3.

Figure 3

Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP‐INTEND) values on the left and Hammersmith Functional Motor Scale/ extended version (HFMSE) values on the right in treated children at baseline and 6 months post dosing with onasemnogene abeparvovec.